Table 2.
Drug Dosage
| Control group | Intervention group | ||||||
|---|---|---|---|---|---|---|---|
| Parameter | Total, N | Correct, n(%) | Excessive, n(%) | Total, N | Correct, n(%) | Excessive, n(%) | P-Value |
| No. of drugs | 70 | 23 (33) | 47 (67) | 192 | 155 (81) | 37 (19) | <.001 |
| Digoxin | 18 | 16 (89) | 2 (11) | 37 | 32 (86) | 5 (14) | NS |
| Antibiotics* | 25 | 4 (16) | 21 (84) | 54 | 42 (78) | 12 (22) | <.001 |
| Cardiovascular drugs | 4 | 1 (25) | 3 (75) | 39 | 30 (77) | 9 (23) | NS |
| H2-blocking agents | 20 | 1 (5) | 19 (95) | 51 | 41 (80) | 10 (20) | <.001 |
| Antimycotics | 3 | 1 (33) | 2 (67) | 8 | 8 (100) | 0 (0) | NS |
| Antivirals | 0 | 0 | 0 | 3 | 2 (67) | 1 (33) | — |
*
Aminoglycosides for which an effective therapeutic drug monitoring program was in place were not included.